← Human Trials & Peer-Reviewed Studies

Efficacy of a Personalized mHealth App in Improving Micronutrient Supplement Use Among Pregnant Women in Karachi, Pakistan: Parallel-Group Randomized Controlled Trial.

Plain-language guide to PMID 40203301 (2025): randomized controlled trial of Copper (Supplement).

Key Facts

PMID
40203301
Journal
Journal of medical Internet research
Year
2025
Study type
Randomized Controlled Trial
Authors
Vadsaria K et al. (5 authors)
DOI
10.2196/67166
Registered trial
NCT04216446

What This Study Did, in Plain Language

What Was Tested

Researchers studied Copper (Supplement) in this randomized controlled trial publication.

Data were analyzed using Stata (version 14), with random-effects linear and logistic panel regression to compare CSUS and supplement use between the 2 groups from baseline to endline.

Why It Was Studied

Micronutrient deficiencies in folate, ferritin, calcium, and vitamin D are common during pregnancy in low- and middle-income countries, often due to inadequate diets.

Micronutrient supplementation can address this need, whereas innovative awareness strategies in antenatal practices could enhance supplement use compliance.

Who Took Part

By PubMed's age tags, the people studied were young adults and adults, women only.

In an unblinded randomized controlled trial, the researchers enrolled 306 first-trimester pregnant women from Aga Khan University Hospital between January 2020 and September 2021 who owned smartphones with internet connection.

Women on regular medications or with dietary restrictions or critical illnesses were excluded.

How the Study Was Run

In design terms this was a randomized study.

The participants were allocated by chance, so the Copper (Supplement) group and the comparison group should start out alike.

The comparison group received standard face-to-face counseling at 6, 12, 18, and 24 weeks after enrollment.

Baseline sociodemographic, obstetrics, anthropometric, dietary, and lifestyle data were collected through face-to-face interviews.

Scores were summed to calculate the cumulative supplement use score (CSUS; 0-12), with higher scores indicating greater inadequacy.

Every fourth woman was invited for biochemical micronutrient assessment.

What Was Measured

PubMed files the paper under topics including Dietary Supplements, Micronutrients, Mobile Applications, Pakistan and Telemedicine.

The authors tagged it with the keywords artificial intelligence, calcium, folic acid, iron, micronutrient deficiencies and mobile health intervention.

What This Means in Plain Language

The paper is a randomized study of Copper (Supplement).

Results are reported in around 8 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2025 (Journal of medical Internet research), a journal based in Canada.

More context: the Copper (Supplement) compound page, all human trials.

Our Notes on the Compound

Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.